Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates

Amicus Therapeutics (FOLD) Tops Q1 EPS by 5c, Misses on Revenue

May 1, 2025 7:06 AM EDT

(Updated - May 1, 2025 10:00 AM EDT)

Amicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of $0.03, $0.05 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $125.25 million versus the consensus estimate of $136.65 million.

For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.

... More